| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/17/2023 |
4
| Lemaitre Dan (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Sold 43,450 shares
@ $56.9845, valued at
$2.5M
Exercised 1,450 options to buy
@ $23.95, valued at
$34.7k
Exercised 10,500 options to buy
@ $24.1, valued at
$253.1k
Exercised 14,000 options to buy
@ $25.52, valued at
$357.3k
Exercised 17,500 options to buy
@ $26.27, valued at
$459.7k
|
|
| 05/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/04/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
8-K
| Other Events Interactive Data |
| 05/02/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/28/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/17/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 04/03/2023 |
8-K
| Other Events Interactive Data |
| 03/29/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 03/28/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 03/24/2023 |
S-4/A
| Form S-4/A - Registration of securities, business combinations: [Amend] |
| 03/16/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 02/27/2023 |
4
| ZARRILLI STEPHEN T (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $75.18, valued at
$1.1M
|
|
| 02/27/2023 |
4
| TOBIN JAMES R (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $75.18, valued at
$1.1M
|
|
| 02/27/2023 |
4
| RHOADS ANN D (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $75.18, valued at
$1.1M
|
|
| 02/27/2023 |
4
| Lemaitre Dan (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $75.18, valued at
$1.1M
|
|
| 02/27/2023 |
4
| Douglas Robert Andrew (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $75.18, valued at
$1.1M
|
|
| 02/27/2023 |
4
| Davidar David D (Director) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 15,000 options to buy
@ $75.18, valued at
$1.1M
|
|
| 02/27/2023 |
4
| Huller Kelly (SVP, GC, Corporate Secretary) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 30,000 options to buy
@ $75.18, valued at
$2.3M
|
|
| 02/27/2023 |
4
| Pfeil Keith W (SVP, CFO) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 40,000 options to buy
@ $75.18, valued at
$3M
|
|
| 02/27/2023 |
4
| Paul David C (Executive Chairman) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 75,000 options to buy
@ $75.18, valued at
$5.6M
|
|
| 02/27/2023 |
4
| Scavilla Daniel T (President, CEO) has filed a Form 4 on GLOBUS MEDICAL INC|
Txns:
| Granted 100,000 options to buy
@ $75.18, valued at
$7.5M
|
|
| 02/22/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 02/21/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/14/2023 |
SC 13G
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC reports a 8% stake in GLOBUS MEDICAL INC |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|